GRI

Anvisa clarifies and determines rules for manipulating LPG-1 pens

News Healthcare & Pharma Consultations
Date: 25th Aug, 2025 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

On August 25, 2025, the National Health Surveillance Agency (Anvisa) issued an update regarding Anvisa clarifies and determines rules for manipulating LPG-1 pens. The agency approved Technical Note 200/2025 and published a decree providing guidelines and determinations on importing and manipulating active pharmaceutical ingredients (APIs) agonists of GLP-1, specifically Ozempic, Saxenda, and Mounjaro.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Federal Trade Commission Issues Request for Information on Employee Noncompete Agreements
Date: 4th Sep, 2025 Source: Federal Trade Commission Country: USA
News Competition Consultations
Anvisa reinforces guidelines on imports of health treatment products
Date: 4th Sep, 2025 Source: National Health Surveillance Agency (Anvisa) Country: Brazil
News Healthcare & Pharma Guidance
ACER will consult on amendments to the REMIT market participant registration format and the CEREMP platform
Date: 4th Sep, 2025 Source: European Union Agency for the Cooperation of Energy Regulators (ACER) Country: European Union
News Environment Consultations

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales